Angiogenic Switch
|
disease |
|
Neoplastic Process
|
96
|
3
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Alveolar Bone Loss
|
disease |
Musculoskeletal Diseases; Stomatognathic Diseases
|
Disease or Syndrome
|
101
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hemolytic-Uremic Syndrome
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
110
|
7
|
0.020 |
None |
1.000 |
2 |
|
1988 |
1999 |
Androgenetic Alopecia
|
disease |
Pathological Conditions, Signs and Symptoms; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
112
|
107
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Disseminated Intravascular Coagulation
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
117
|
3
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2015 |
Hyperplasia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
131
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Parathyroid Adenoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
133
|
12
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Situs Inversus
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Congenital Abnormality
|
138
|
6
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Metastatic castration-resistant prostate cancer
|
disease |
|
Neoplastic Process
|
140
|
2
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Sleep Apnea Syndromes
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
148
|
18
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Exudative age-related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
158
|
109
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Drug usage
|
phenotype |
Chemically-Induced Disorders; Mental Disorders
|
Mental or Behavioral Dysfunction
|
170
|
21
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Tumor Promotion
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
170
|
2
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Iron deficiency
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
179
|
13
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Neoplasm Invasiveness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Pathologic Function
|
193
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Glycogen storage disease type II
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
194
|
269
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute infectious disease
|
group |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
198
|
5
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Respiration Disorders
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
208
|
6
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Thyroid associated opthalmopathies
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Eye Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
211
|
49
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Bacteremia
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
233
|
7
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Leukemia, B-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
239
|
2
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Myositis
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
254
|
43
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Promyelocytic leukemia
|
disease |
|
Neoplastic Process
|
255
|
2
|
0.010 |
None |
1.000 |
1 |
|
1994 |
1994 |
Cachexia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
273
|
11
|
0.340 |
None |
1.000 |
6 |
|
2001 |
2013 |
HER2-positive carcinoma of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
288
|
26
|
0.010 |
None |
1.000 |
1 |
1
|
2011 |
2011 |